Form 4: Morgan Stanley Co-President Sells Over 43,000 Shares Under Pre-Arranged Plan

Morgan Stanley Co-President Andrew M. Saperstein reported the sale of 43,566 shares of common stock from a grantor retained annuity trust in pre-arranged transactions.

Summary

• Andrew M. Saperstein, Co-President of Morgan Stanley, reported transactions involving the company's common stock.
• On July 17, 2025, Saperstein disposed of 22,207 shares at a weighted average price of $140.6797 per share, with prices ranging from $140.01 to $141.00.
• On the same date, an additional 21,359 shares were sold at a weighted average price of $141.2819 per share, with prices ranging from $141.01 to $141.68.
• These sales were conducted from a Grantor Retained Annuity Trust, representing indirect beneficial ownership.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
• A total of 43,566 shares previously directly owned were contributed to the grantor retained annuity trust since the last report.
• Following these transactions, Saperstein's indirect beneficial ownership through the trust is 0 shares, while direct beneficial ownership stands at 294,250.416 shares.

Sentiment

Score: 5

Explanation: Neutral. The document reports routine insider stock sales under a pre-arranged plan (10b5-1), which is a common practice for executives. While it's a sale, the pre-planned nature mitigates immediate negative sentiment, as it's not necessarily a reaction to new negative information.

Positives

• The transactions were conducted under a Rule 10b5-1(c) plan, which indicates the sales were pre-scheduled and not a reaction to immediate market conditions or new, undisclosed information.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by investors as it reduces management's direct stake in the company.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports past insider transactions.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It does not provide broader industry context or trends. Insider sales, especially those under 10b5-1 plans, are common for executives managing personal finances and diversifying portfolios.

Stakeholder Impact

• Shareholders: May observe a reduction in direct insider ownership, though the pre-planned nature (10b5-1) suggests it is not based on new negative information.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Recommendation

Keywords

Morgan Stanley, MS, Andrew Saperstein, Insider Trading, Form 4, Stock Sale, Beneficial Ownership, Grantor Retained Annuity Trust, 10b5-1 Plan